TCOT
MRNA icon

Trust Company of Toledo’s Moderna MRNA Stock Holding History

Trust Company of Toledo’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$254 – 907
2026
Q1 		$254 Buy
+5
New +$233 ﹤0.01% 833
2025
Q4 		– Sell
-122
Closed -$3.15K – 784
2025
Q3 		$3.15K Sell
122
-100
-45% -$2.79K ﹤0.01% 698
2025
Q2 		$6.13K Buy
+222
New +$5.85K ﹤0.01% 646

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Trust Company of Toledo's MRNA Position: Q2 2026 in Review

Trust Company of Toledo sold out of Moderna (MRNA) in Q2 2026, closing a stake of 5 shares — an estimated $254 sold.

Trust Company of Toledo first reported a position in MRNA in Q2 2025 and held it in 3 quarters. The position peaked at $6.13K in Q2 2025. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Trust Company of Toledo reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Trust Company of Toledo sold 5 Moderna shares in Q2 2026, an estimated $254.
  • Trust Company of Toledo first reported a position in Moderna in Q2 2025 and held it in 3 quarters.
  • Trust Company of Toledo's Moderna position peaked at $6.13K in Q2 2025.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.